Recombinant baculovirus vector development for universal vaccine production against human common cold virus, Rhinovirus

1. Patricio Gabarrón
2. Jose Carlos Luque
3. Elena de la Torre
4. Félix Risco
5. Juan José Infante

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria

Sustainable development goals

Bibliographic References

• Palmenberg, A. C., Spiro, D., Kuzmickas, R., Wang, S., Djikeng, A., Rathe, J. A., . . . Liggett, S. B. (2009). Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science, 324(5923), 55-59. doi:10.1126/science.1165557
• Felberbaum, R. S. (2015). The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors. Biotechnology Journal, 10(5), 702.
• Son, J. H., Buchholz, R., Park, J., & Kim, S. K. (2006). Production of baculoviruses and expression of green fluorescent protein in immobilised Sf21 insect cell cultivation. Biochemical Engineering Journal, 29(1), 55-61. doi:10.1016/j.bej.2005.02.02

Data source: Dialnet